1
HD stimulated with irradiated clinical isolates from multidrug resistant (MDR) outbreaks M (Haarlem family) and Ra (Latin American-Mediterranean family), as well as drug-susceptible isolates belonging to the same families and laboratory strain H37Rv for 48 hours in T-cell subsets by flow cytometry.
Results. We observed that: (1) MDR strains M and Ra are stronger IL-17 inducers than drug-susceptible Mtb strains of the Haarlem and Latin American-Mediterranean families, (2) MDR-TB patients show the highest IL-17 expression that is independent on the strain, (3) IL-17 expression is dependent on CD4 1 and CD8 1 T cells associates with persistently high antigen load.
Conclusions. IL-17-producing T cells could play an immunopathological role in MDR-TB promoting severe tissue damage, which may be associated with the low effectiveness of the second-line drugs employed in the treatment.
Interleukin 17 (IL-17) is a proinflammatory cytokine that plays an important role in autoimmunity [1] , graft rejection [2] , and immune responses against intracellular pathogens [3] . By inducing the recruitment and activation of polymorphonuclear neutrophils (PMN) and triggering the production of proinflammatory cytokines and chemokines [4] , IL-17 is also associated with tissuedamaging inflammation [5] . Although CD4 1 T cells are the main source of IL-17 [4, [6] [7] [8] [9] [10] , CD8 1 T, cdT, natural killer T (NKT), and natural killer (NK) cells also produce IL-17 [11] [12] [13] . Upon challenge with Mycobacterium tuberculosis (Mtb), an expansion of CD4 1 T and cdT cells producing IL-17 occurs in the lungs of vaccinated mice together with a recruitment of interferon c 1 (IFNc In the early 1990s, outbreaks of multidrug resistant tuberculosis (MDR-TB) caused by Mtb strains showing resistance to at least isoniazid and rifampin [19] took place in the cities of Buenos Aires and Rosario, Argentina [20, 21] . Although these strains had been isolated from human immunodeficiency virus (HIV)-infected patients, they disseminated to immunocompetent individuals [22] [23] [24] . Epidemiological, bacteriological, and genotyping data allowed the identification of the outbreak strains M (Haarlem family) and Ra (Latin American-Mediterranean) families. In particular, strain M appears to be highly prosperous in the country and is able to build up further drug resistance without impairing its ability to spread.
Recently, we have demonstrated that MDR strains M and Ra induce an altered T-helper 1/T-helper 2 (Th1/Th2) profile in T cells from PPD 1 HD and from patients with TB, strain M being a weaker inducer of IFNc and of CD8-dependent cytotoxic activity [25] . In the present work, we evaluated the ability of strains M and Ra to stimulate IL-17 in TB patients and in PPD 1 HD. We showed that strains M and Ra significantly increase the level of IL-17 1 cells. The highest CD4 1 and CD8 1 T-cell-dependent IL-17 response was observed in MDR-TB patients, and it was strongly associated with persistently high antigen load.
MATERIAL AND METHODS

Patients
Blood samples were obtained from patients with TB hospitalized in F. J. Muñiz Hospital, Buenos Aires, Argentina. Informed consent was obtained from patients according to the guidelines of the ethics committee of the hospital. All patients were diagnosed by the presence of recent clinical respiratory symptoms, abnormal chest radiography, a sputum smear positive for acidfast bacilli (AFB), and the identification of Mtb in culture. Exclusion criteria included a positive test for HIV and the presence of concurrent infectious diseases or noninfectious conditions (cancer, diabetes, or steroid therapy). Sputum smear examination, mycobacterial culture, strain identification, and drug susceptibility testing were performed according to standard procedures. Susceptibility to isoniazid, rifampin, and to any other specific anti-TB drugs was tested as previously described [26] . Available MDR Mtb isolates were genotyped by IS6110 DNA fingerprinting and spoligotyping using standardized protocols [27, 28] 
Immunofluorescence Analysis
For surface staining, ex vivo or cultured PBMCs were incubated with PE-Cy5/FITC-anti-CD4 or anti-CD8, and FITC-antigamma-delta TCR (all from BD Bioscience) and PE-anti-IL-23 receptor (IL-23R, R&D System Inc.) or the corresponding isotype monoclonal antibodies (mAb) for 20 minutes at 4°C. Prior to intracellular cytokine staining, Brefeldin A (5 lg/mL; Sigma Chemical Co.) was added for the last 4 hours of culture to block cytokine secretion. Then cells were surface-stained for CD4, CD8, or cdTCR expression, fixed and permeabilized according to the manufacturer's instructions (Perm2, BD Bioscience) before PE-anti-IL-17 and FITC-anti-IFNc (BD Bioscience) or the corresponding isotypes were added.
Stained cells were washed, fixed with 0.5% paraformaldehyde, and suspended in Isoflow (BD Bioscience) for acquisition. Sixtythousand events were acquired using a FACSCan flow cytometer (BD Bioscience). FCS Express software (De Novo Software) was used for analysis. Lymphocyte gates were set according to forward and side-scatter parameters, excluding cell debris and apoptotic cells. Results were expressed as percentages of positive cells in the lymphocyte population or within CD4 ) expressing IL-17 were determined in the lymphocyte gate. Given that in our experimental conditions the expression of IL-17 was consistently higher at 48 hours compared with 5 days, all experiments were performed only at 48 hours.
As shown in Figure Having observed the high capacity of strains M and Ra to induce IL-17, we wanted to determine whether it was a characteristic of these particular outbreak MDR strains, or whether it was shared with drug-susceptible Mtb strains belonging to their respective families. For this purpose, 2 fully drug-susceptible clinical isolates were selected, strain 10406 (Ls), a representative of the Latin American-Mediterranean family related to strain Ra; and 10475 (Hs), a representative of the Haarlem family related to strain M. As observed in Figure 2 , Hs and Ls expanded a lower percentage of IL-17 1 cells than M and Ra in MDR-TB, while in PPD1HD, they did not (data not shown). Given that human Th17 cells constitutively express the receptor for IL-23 (IL-23R) [29] , its expression was determined in PBMCs as shown in Supplementary Figure 2 (online only). As shown in Figure 4D ).
Correlation Between IL-17 Expression and Clinical Features
In MDR-TB patients, we evaluated whether in vitro Mtbstimulated IL-17 expression correlated with clinical data such as presence/absence of AFB in sputum using Ziehl-Neelsen stained smears, antigen load (number of bacilli/field), disease severity, primary and acquired MDR-TB (primary MDR-TB was defined as that diagnosed in a patient without previous TB treatment; acquired MDR-TB was defined as MDR-TB patients with a history of previous TB chemotherapy), days of treatment at the time of the study, and days to reach AFB-smear-negative sputum (AFB Figure 5C ). Remarkably, at the time of the study, all S-TB patients showed a primary disease and were AFB 1 , but the levels of Mtb-stimulated IL-17 1 cells in these patients were lower than in AFB 1 MDR-TB patients (Figure 4 ).
We also observed that during TB treatment, the levels of CD4 
IL-17
1 ( Figure 6A ) and IL-17
1 IFNc 2 within CD4 1 cells decreased ( Figure 6B ). Besides, we observed that the fewer the days to reach a negative AFB, the higher the IFNc-producing cells; that is, the %IL-17 [39] . Thereby, it is tempting to hypothesize that MDR strains promote Th17-inducing conditions. The expansion of cdTCR 1 IL-17 1 cells by Mtb observed in TB, and particularly in MDR-TB, are in accordance with previous reports in humans as well as in mouse models [11, 18, 32] . In this context, the higher IL-23R expression on lymphocytes may also explain the greater IL-17 1 cell levels found in TB patients. It is known that IL-23 is required for Th17 development because mice deficient in IL-23p19 are unable to hold a proper Th17 response; although upon Mtb infection, IL-23 is not required for initial differentiation of IL-17-producing cells, its expression is required to sustain IL-17 production [14, 17] . So, both MDR strains might be stronger IL-23 producers, tipping IL-23/IL-12 balance to Th17 response. It is known that IL-12p40 is shared by both IL-12p70 and IL-23 [40, 41] so the relative expression of IL-23p19 and IL-12p35 subunits would balance the secretion of bioactive IL-12p70 and IL-23. Although this is not well understood in TB, it is likely that further cytokine signaling would be important to sustain a Th1 or a Th17 response. IFNc has been demonstrated to negatively regulate the production of IL-17 in a mouse model of mycobacterial infection [42] , while the levels of IFNc-producing cdT cells were reciprocally associated with IL-17-producing cdT cells in TB patients [18] . In this line, CD4 HD, which is in accordance with other studies [30] . Consistently with the low ability to stimulate IFNc production that the low proportion of double-positive cells in MDR-TB could also be associated with the impaired Mtb-induced Th1 response observed in these patients [25, 45, 46] . However, we cannot exclude anti-inflammatory cytokines, such as IL-4 or transforming growth factor b (TGF-b), which could also be contributing to the differential activation of these 2 Th17 subsets. Current studies are being performed to evaluate the role of cytokines related to the IFNc/IL-12 and IL-17/IL-23 axes and anti-inflammatory cytokines on Th17 response induced by MDR M and Ra strains. H37Rv-infected mice subjected to repeated BCG vaccination display an increased Th17 response with increased PMN influx and lung tissue damage [47] . As immunopathology is a central feature of Mtb lung infection and its regulation during chronic Mtb infection is essential for host survival, IL-17 and Th17 cells may play a role by inducing the recruitment and activation of PMN and triggering the production of proinflammatory cytokines and chemokines [4] . Neutrophil recruitment and survival may be one of the mechanisms by which IL-17 promotes granuloma organization. However, this response must be regulated because large PMN accumulation in the lung is generally associated with a bad prognosis and increased lung pathology. It has recently been asserted that PMN are the predominant infected cells in active TB patients, suggesting that these cells provide a permissive environment for bacillary replication [48] . In this study, we showed that bacterial load is associated with increased IL-17-producing CD4 is independent on the strain but is closely associated with persistent and high antigen load, suggesting an immunopathological role in MDR-TB.
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